Dusseldorf - Delayed Quote EUR
Koninklijke Philips NV (PHIA.DU)
21.40
+0.20
+(0.94%)
As of 8:10:14 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
18,021,000
18,021,000
18,169,000
17,827,000
17,156,000
Cost of Revenue
10,248,000
10,248,000
10,721,000
10,633,000
9,988,000
Gross Profit
7,773,000
7,773,000
7,448,000
7,194,000
7,168,000
Operating Expense
7,260,000
7,260,000
7,616,000
7,371,000
6,545,000
Operating Income
513,000
513,000
-168,000
-177,000
623,000
Net Non Operating Interest Income Expense
-257,000
-257,000
-266,000
-223,000
-137,000
Other Income Expense
-133,000
-133,000
-92,000
-1,332,000
22,000
Pretax Income
123,000
123,000
-526,000
-1,731,000
509,000
Tax Provision
963,000
963,000
-73,000
-113,000
-103,000
Net Income Common Stockholders
-702,000
-702,000
-466,000
-1,608,000
3,319,000
Diluted NI Available to Com Stockholders
-702,000
-702,000
-466,000
-1,608,000
3,319,000
Basic EPS
-0.75
--
-0.49
-1.69
3.40
Diluted EPS
-0.75
--
-0.49
-1.69
3.38
Basic Average Shares
933,370.81
--
948,300.67
951,811.38
976,933.94
Diluted Average Shares
933,370.81
--
948,300.67
951,811.38
982,749.48
Total Operating Income as Reported
529,000
529,000
-115,000
-1,529,000
553,000
Total Expenses
17,508,000
17,508,000
18,337,000
18,004,000
16,533,000
Net Income from Continuing & Discontinued Operation
-702,000
-702,000
-466,000
-1,608,000
3,319,000
Normalized Income
-837,322
-837,322
-460,980
-377,450
588,500
Interest Income
79,000
79,000
46,000
25,000
18,000
Interest Expense
337,000
337,000
306,000
244,000
164,000
Net Interest Income
-257,000
-257,000
-266,000
-223,000
-137,000
EBIT
460,000
460,000
-220,000
-1,487,000
673,000
EBITDA
1,849,000
1,849,000
1,041,000
115,000
1,996,000
Reconciled Cost of Revenue
10,248,000
10,248,000
10,721,000
10,633,000
9,988,000
Reconciled Depreciation
1,389,000
1,389,000
1,261,000
1,602,000
1,323,000
Net Income from Continuing Operation Net Minority Interest
-844,000
-844,000
-456,000
-1,621,000
608,000
Total Unusual Items Excluding Goodwill
-9,000
-9,000
6,000
-1,330,000
26,000
Total Unusual Items
-9,000
-9,000
6,000
-1,330,000
26,000
Normalized EBITDA
1,858,000
1,858,000
1,035,000
1,445,000
1,970,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,322
-2,322
1,020
-86,450
6,500
12/31/2021 - 7/3/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RJV.F SomnoMed Limited
0.2240
-0.88%
SRBZF Stratec SE
72.96
0.00%
RJV.SG SomnoMed Ltd
0.2240
+0.90%
STSEY Stratec SE
6.70
0.00%
RIOXF RION CO LTD
19.75
0.00%
ABL.MU Abbott Laboratories
113.50
-0.96%
SBS.DU Stratec SE
25.60
+3.64%
SBS.HM Stratec SE
25.00
-1.77%
EE5.MU El.En. SpA
8.52
+2.16%
IDYLF Imaging Dynamics Company Ltd.
0.0300
0.00%